{"disease":{"id":"precursor-cell-lymphoblastic-leukemia-lymphoma","name":"precursor cell lymphoblastic leukemia lymphoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03985826","title":"Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia","phase":"","overall_status":"COMPLETED","enrollment_count":7348,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT03545659","title":"Childhood Acute Lymphoblastic Leukaemia: Follow-Up","phase":"","overall_status":"COMPLETED","enrollment_count":277,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06237192","title":"MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"National Research Center for Hematology, Russia","has_results":false},{"nct_id":"NCT07469592","title":"eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":165,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT07499128","title":"Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":136,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06560879","title":"Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":120,"lead_sponsor_name":"National Institute of Pediatrics, Mexico","has_results":false},{"nct_id":"NCT03677596","title":"A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05660473","title":"Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT05873322","title":"Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT05024357","title":"A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT05968963","title":"Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT05026229","title":"A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT02454270","title":"A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":59,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT01747499","title":"Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT02390752","title":"Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":54,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06387121","title":"Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":53,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06880913","title":"Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03384654","title":"A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT04472286","title":"Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University of Nebraska","has_results":false},{"nct_id":"NCT07522905","title":"Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Comenius University","has_results":false},{"nct_id":"NCT06874946","title":"Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/LBL","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04456959","title":"InO - A Retrospective Study of UK Patients With Leukaemia","phase":"","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03743246","title":"A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT06765876","title":"CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Institute of Hematology and Blood Transfusion, Czech Republic","has_results":false},{"nct_id":"NCT06709469","title":"Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Instituto de Investigación Hospital Universitario La Paz","has_results":false},{"nct_id":"NCT03888534","title":"Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Millennium Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT02973191","title":"A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Celgene","has_results":false}],"total":27},"guidelines":[],"source":"Drug Landscape verified database"}